Synopsis: Enalapril maleate 1 is an orally active angiotensin-converting enzyme inhibitor. It
lowers peripheral vascular resistance without causing an increase in heart rate. Enalapril 10 …

Background: Measurement of plasma renin is important for the clinical assessment of
hypertensive patients. The most common methods for measuring plasma renin are the …

Enalapril maleate is a prodrug which when administered orally is hydrolysed to release the
active converting enzyme inhibitor enalaprilat. Enalapril maleate is 60% absorbed and 40 …

Synopsis Lisinopril is an orally active angiotensin-converting enzyme (ACE) inhibitor which
at dosages of 20 to 80mg once daily is effective in lowering blood pressure in all grades of …

Enalapril, an orally-active, long-acting, nonsulphydryl angiotensin-converting enzyme (ACE)
inhibitor, is extensively hydrolysed in vivo to enalaprilat, its bioactive form. Bioactivation …

The orally active angiotensin-converting inhibitors (ACE inhibitors) such as captopril and
enalapril represent a significant therapeutic advance in the treatment of hypertension and …

The angiotensin converting enzyme inhibitors are an important therapeutic advance in the
treatment of patients with hypertension and congestive heart failure. In addition, they are …

To find out if there are one or more criteria to guide selection among the ACE inhibitors for
the treatment of arterial hypertension, we have reviewed the principal pharmacokinetic and …

Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease. The
pathogenesis of hypertension in autosomal-dominant polycystic kidney disease (ADPKD) is …

The kinetics of captopril plasma levels and of the drug‐induced plasma converting enzyme
activity (PCEA), plasma renin activity (PRA) and diastolic blood pressure (DBP) …